Xalkori (crizotinib) — Medica
Anaplastic Large Cell Lymphoma (ALK-positive)
Initial criteria
- age ≥ 1 year
- disease is anaplastic lymphoma kinase (ALK)-positive
- EITHER medication is used for palliative-intent therapy OR patient has relapsed or refractory disease
Approval duration
1 year